Mayur Ian Somaiya, Chief Financial Officer at TCR2 THERAPEUTICS INC. (TCRR), sold 2,000 shares at $35.00 ($70K) on 2020-12-14, disclosed to the SEC on 2020-12-16.
Open-market sale of $70k TCRR by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| TCRR | SELL | 2020-11-19 | $110K | — | Filing → |